Total antioxidant capacity of cerebrospinal fluid is decreased in patients with motor neuron disease

[1]  M. Beal,et al.  Mitochondrial dysfunction and amyotrophic lateral sclerosis , 2006, Muscle & nerve.

[2]  Zuoshang Xu,et al.  Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. , 2005, Mitochondrion.

[3]  M. Smith,et al.  Oxidative stress mechanisms and potential therapeutics in Alzheimer disease , 2005, Journal of Neural Transmission.

[4]  B. O. Boehm,et al.  The advanced glycation end-product N ɛ-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis , 2004, Neuroscience Letters.

[5]  M. Beal.  Mitochondrial Dysfunction and Oxidative Damage in Alzheimer's and Parkinson's Diseases and Coenzyme Q10 as a Potential Treatment , 2004, Journal of bioenergetics and biomembranes.

[6]  J. Andersen,et al.  Oxidative stress in neurodegeneration: cause or consequence? , 2004, Nature Reviews Neuroscience.

[7]  M. Serafini,et al.  Understanding the association between dietary antioxidants, redox status and disease: is the Total Antioxidant Capacity the right tool? , 2004, Redox report : communications in free radical research.

[8]  Colin L. Masters,et al.  Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.

[9]  F. Bricaire,et al.  Neurodegenerative diseases and oxidative stress. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  G. Kaur,et al.  Prolonged glutamate excitotoxicity: Effects on mitochondrial antioxidants and antioxidant enzymes , 2004, Molecular and Cellular Biochemistry.

[11]  S. Appel,et al.  Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis , 2003, Current opinion in rheumatology.

[12]  G. Rotilio,et al.  Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals , 2003, Brain Research Bulletin.

[13]  T D Koepsell,et al.  Prognosis in amyotrophic lateral sclerosis , 2003, Neurology.

[14]  J. Iłżecka.  Total antioxidant status is increased in the serum of amyotrophic lateral sclerosis patients , 2003, Scandinavian journal of clinical and laboratory investigation.

[15]  R. Miller,et al.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[16]  A. Chakrabartty,et al.  Oxidation-induced Misfolding and Aggregation of Superoxide Dismutase and Its Implications for Amyotrophic Lateral Sclerosis* , 2002, The Journal of Biological Chemistry.

[17]  M. Mattson,et al.  Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress–induced death of motor neurons in amyotrophic lateral sclerosis , 2002, Annals of neurology.

[18]  J. Morrow,et al.  Factors associated with oxidative stress in human populations. , 2002, American journal of epidemiology.

[19]  F. Menzies,et al.  Mitochondrial involvement in amyotrophic lateral sclerosis , 2002, Neurochemistry International.

[20]  S Cluskey,et al.  Mechanisms of neurodegeneration in amyotrophic lateral sclerosis , 2001, Molecular pathology : MP.

[21]  Jeffrey D. Rothstein,et al.  From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.

[22]  N. Elsayed,et al.  Antioxidant mobilization in response to oxidative stress: a dynamic environmental-nutritional interaction. , 2001, Nutrition.

[23]  R. Browne,et al.  Correlates of markers of oxidative status in the general population. , 1998, American journal of epidemiology.

[24]  B. Halliwell,et al.  Role of Free Radicals in the Neurodegenerative Diseases , 2001, Drugs & aging.

[25]  V. Meininger,et al.  Blood oxidative stress in amyotrophic lateral sclerosis , 2000, Journal of the Neurological Sciences.

[26]  C. Elger,et al.  Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. , 2000, Brain : a journal of neurology.

[27]  M. Donaghy.  Classification and clinical features of motor neurone diseases and motor neuropathies in adults , 1999, Journal of Neurology.

[28]  Ole A. Andreassen,et al.  Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis , 1999, Nature Medicine.

[29]  M. Beal,et al.  Elevated “Hydroxyl Radical” Generation In Vivo in an Animal Model of Amyotrophic Lateral Sclerosis , 1998, Journal of neurochemistry.

[30]  P. Bickford,et al.  Age-related neurodegeneration and oxidative stress: putative nutritional intervention. , 1998, Neurologic clinics.

[31]  H. Alho,et al.  Assay of antioxidant capacity of human plasma and CSF in aging and disease. , 1998, Restorative neurology and neuroscience.

[32]  F. Jiménez-Jiménez,et al.  Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis , 1998, Journal of Neural Transmission.

[33]  Robert H. Brown,et al.  Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis , 1997, Journal of neurochemistry.

[34]  Robert H. Brown,et al.  Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis , 1997, Annals of neurology.

[35]  D. Price,et al.  Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Y. Itoyama,et al.  Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. , 1997, Neurological research.

[37]  J J Strain,et al.  The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. , 1996, Analytical biochemistry.

[38]  H. Kleiner,et al.  Evidence for DNA damage in amyotrophic lateral sclerosis. , 1996, Muscle & nerve.

[39]  J. Peltola,et al.  The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. , 1996, Free radical biology & medicine.

[40]  R. Prior,et al.  Antioxidant capacity decreases during growth but not aging in rat serum and brain. , 1996, Archives of gerontology and geriatrics.

[41]  P. Ince,et al.  Oxidative damage to protein in sporadic motor neuron disease spinal cord , 1995, Annals of neurology.

[42]  A. Ferro-Luzzi,et al.  A fluorescence-based method for measuring total plasma antioxidant capability. , 1995, Free radical biology & medicine.

[43]  Robert H. Brown,et al.  Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis , 1993, Journal of neurochemistry.